Intra-Cellular Therapies, Inc.
Total Trades
140
Buys
0
Sells
74
Largest Trade
N/A
Insiders
8
Institutional Funds
1
Inst. Value
$1K–$15K
Activist Filings
11
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Neumann Mark | EVP | SELL | $1M+ | 55K | $58.79 | Aug 9, 2023 |
| Durgam Suresh K. | EVP | SELL | $100K–$500K | 2K | $65.00 | Jul 20, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $1M+ | 82K | $63.97 | Jun 16, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | $1M+ | 82K | $42.30 | Jun 16, 2023 |
| VAN NOSTRAND ROBERT L | Director | EXERCISE | $100K–$500K | 10K | $13.05 | Apr 19, 2023 |
| VAN NOSTRAND ROBERT L | Director | SELL | $500K+ | 10K | $63.00 | Apr 19, 2023 |
| Neumann Mark | EVP | SELL | $500K+ | 16K | $54.31 | Mar 30, 2023 |
| Durgam Suresh K. | EVP | EXERCISE | N/A | 7K | — | Mar 13, 2023 |
| Durgam Suresh K. | EVP | SELL | $100K–$500K | 7K | $45.04 | Mar 13, 2023 |
| Neumann Mark | EVP | GRANT | N/A | 17K | — | Mar 13, 2023 |
| Neumann Mark | EVP | EXERCISE | N/A | 7K | — | Mar 13, 2023 |
| Neumann Mark | EVP | SELL | $500K+ | 12K | $43.84 | Mar 13, 2023 |
| Halstead Michael | EVP and General Co… | GRANT | N/A | 17K | — | Mar 13, 2023 |
| Halstead Michael | EVP and General Co… | EXERCISE | N/A | 7K | — | Mar 13, 2023 |
| Halstead Michael | EVP and General Co… | SELL | $1M+ | 24K | $43.66 | Mar 13, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | N/A | 6K | — | Mar 13, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $500K+ | 21K | $43.55 | Mar 13, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | GRANT | N/A | 16K | — | Mar 13, 2023 |
| Mates Sharon | Chairman | SELL | $1M+ | 62K | $43.76 | Mar 13, 2023 |
| Mates Sharon | Chairman | EXERCISE | $50K–$100K | 41K | $1.61 | Mar 13, 2023 |
| Mates Sharon | Chairman | GRANT | N/A | 42K | — | Mar 13, 2023 |
| Neumann Mark | EVP | SELL | $100K–$500K | 7K | $50.01 | Mar 4, 2023 |
| Neumann Mark | EVP | EXERCISE | N/A | 8K | — | Feb 28, 2023 |
| Neumann Mark | EVP | SELL | $100K–$500K | 4K | $47.12 | Feb 28, 2023 |
| Durgam Suresh K. | SVP | SELL | $100K–$500K | 8K | $47.14 | Feb 28, 2023 |
| Durgam Suresh K. | SVP | EXERCISE | N/A | 8K | — | Feb 28, 2023 |
| Halstead Michael | EVP and General Co… | SELL | $100K–$500K | 8K | $47.03 | Feb 28, 2023 |
| Halstead Michael | EVP and General Co… | EXERCISE | N/A | 8K | — | Feb 28, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | N/A | 7K | — | Feb 28, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $100K–$500K | 7K | $47.03 | Feb 28, 2023 |
| Mates Sharon | Chairman | SELL | $1M+ | 23K | $47.03 | Feb 28, 2023 |
| Mates Sharon | Chairman | EXERCISE | $50K–$100K | 53K | $1.86 | Feb 28, 2023 |
| Neumann Mark | EVP | EXERCISE | N/A | 11K | — | Feb 23, 2023 |
| Neumann Mark | EVP | SELL | $100K–$500K | 4K | $47.01 | Feb 23, 2023 |
| Durgam Suresh K. | SVP | EXERCISE | N/A | 8K | — | Feb 23, 2023 |
| Durgam Suresh K. | SVP | SELL | $100K–$500K | 8K | $46.84 | Feb 23, 2023 |
| Halstead Michael | EVP and General Co… | EXERCISE | N/A | 11K | — | Feb 23, 2023 |
| Halstead Michael | EVP and General Co… | SELL | $500K+ | 11K | $46.84 | Feb 23, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | $500K+ | 64K | $10.67 | Feb 23, 2023 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $1M+ | 64K | $49.34 | Feb 23, 2023 |
| Mates Sharon | Chairman | EXERCISE | N/A | 28K | — | Feb 23, 2023 |
| Mates Sharon | Chairman | SELL | $1M+ | 28K | $46.83 | Feb 23, 2023 |
| MARCUS JOEL S | Director | SELL | $100K–$500K | 5K | $50.82 | Dec 21, 2022 |
| Mates Sharon | Chairman | SELL | $1M+ | 33K | $55.00 | Dec 16, 2022 |
| Halstead Michael | EVP and General Co… | SELL | $1M+ | 50K | $53.73 | Dec 3, 2022 |
| Halstead Michael | EVP and General Co… | EXERCISE | $500K+ | 50K | $15.47 | Dec 3, 2022 |
| MARCUS JOEL S | Director | SELL | $500K+ | 10K | $52.30 | Nov 8, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | EXERCISE | $1M+ | 65K | $15.47 | Sep 24, 2022 |
| Hineline Lawrence J. | SVP of Finance CFO | SELL | $1M+ | 65K | $45.63 | Sep 24, 2022 |
| VAN NOSTRAND ROBERT L | Director | SELL | $1M+ | 30K | $57.13 | Aug 12, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 1 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Jun 5, 2025
0.0%
0 shares
SC 13G/A · Feb 7, 2025
2.5%
2.7M shares
SC 13G/A · Nov 12, 2024
10.5%
11.1M shares
SC 13G/A · Nov 8, 2024
5.9%
6.2M shares
SC 13G/A · Oct 24, 2024
5.9%
6.2M shares
JPMORGAN CHASE & CO. 13-2624428
SC 13G · Oct 10, 2024
5.0%
5.3M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.4%
9.1M shares
SC 13G/A · Jan 25, 2024
8.5%
8.2M shares
SC 13G/A · Feb 3, 2023
7.9%
7.4M shares
Wasatch Advisors LP 87-0319391
SC 13G/A · Jan 10, 2023
5.0%
4.7M shares
Wasatch Advisors, Inc. 87-0319391
SC 13G/A · Feb 10, 2022
10.1%
8.2M shares